Lv51
930 积分 2021-03-06 加入
Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial
3小时前
待确认
ARID1A Stimulates Notch-TLL1 Signaling to Induce Cancer-Associated Fibroblast Activation and Intrahepatic Cholangiocarcinoma Development
1个月前
已完结
FGFR2 Fusion-Driven CXCL3 Downregulation Attenuates Neutrophil Recruitment in Intrahepatic Cholangiocarcinoma
1个月前
已完结
Tertiary Lymphoid Structures and Hepatocellular Carcinoma: Guardian and Executioner
1个月前
已完结
Hepatic arterial infusion chemotherapy combined with lenvatinib and programmed death receptor-1 inhibitors for hepatocellular carcinoma with Vp4 portal vein tumor thrombus: a multicenter, propensity score matching comparative study
1个月前
已完结
Real-world outcomes of adjuvant therapy after curative-intent resection for biliary tract cancer
2个月前
已完结
Emerging Anti-Cancer and Repurposed Therapies for Overcoming Multidrug Resistance in Lung Cancer
2个月前
已完结
Ivonescimab delays disease progression
2个月前
已完结
Metastatic Lymph Node Burden and Invasive Tumour Features Inform First Recurrence Patterns After Curative-Intent Resection for Intrahepatic Cholangiocarcinoma
2个月前
已完结
Real-world efficacy of zanidatamab in patients with HER2 positive advanced biliary tract cancers
2个月前
已完结
皖公网安备34019202002308
